β-defensin 39 Activators
β-Defensin 39 emerges as a critical player in the host's innate immune arsenal, contributing to antimicrobial defense against a spectrum of pathogens. Functionally, β-defensin 39 serves as an antimicrobial peptide, exerting bactericidal effects by disrupting microbial membranes and forming an essential component of the first line of defense against infections. The activation of β-defensin 39 involves a sophisticated interplay of cellular signaling pathways influenced by various chemical activators. Compounds such as retinoic acid, thiazolidinedione, sulforaphane, butyrate, genistein, resveratrol, 5-azacytidine, alpha-lipoic acid, luteolin, diallyl disulfide, EGCG, quercetin, and curcumin contribute to the up-regulation of β-defensin 39 through distinct mechanisms
Retinoic acid directly activates β-defensin 39 by binding to retinoic acid receptors (RARs), leading to enhanced transcription. Thiazolidinediones stimulate β-defensin 39 via PPARγ activation, reinforcing the antimicrobial response. Sulforaphane activates β-defensin 39 through the Keap1-Nrf2-ARE pathway, strengthening the innate immune defense. Butyrate acts as a histone deacetylase inhibitor, promoting an open chromatin structure and elevating β-defensin 39 expression.
Genistein indirectly activates β-defensin 39 by inhibiting the PI3K/Akt pathway, influencing FoxO3a-mediated transcription. Resveratrol modulates the Nrf2/ARE pathway, enhancing β-defensin 39 expression as an antioxidant. 5-Azacytidine directly activates β-defensin 39 by demethylating the promoter region, relieving epigenetic repression. Alpha-lipoic acid activates β-defensin 39 through the Nrf2/ARE pathway, contributing to antimicrobial defense. Luteolin modulates the AP-1 pathway, alleviating negative regulation on DEFB39 expression. Diallyl disulfide influences the MAPK pathway, enhancing β-defensin 39 transcription. EGCG inhibits the NF-κB pathway, leading to increased β-defensin 39 expression. Quercetin modulates the AP-1 pathway, positively regulating β-defensin 39 synthesis. Curcumin activates β-defensin 39 through the MAPK pathway, reinforcing the antimicrobial defense mechanism. Understanding these activation mechanisms not only elucidates the intricate regulation of β-defensin 39 but also provides potential avenues for manipulating innate immunity to enhance the host's ability to combat microbial challenges. The diversity of chemical activators highlights the complexity of innate immune responses and their implications for bolstering antimicrobial defenses.
SEE ALSO...
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a direct activator, binds to retinoic acid receptors (RARs), forming a complex that translocates to the DEFB39 promoter. This enhances transcription, resulting in increased β-defensin 39 expression. The up-regulation contributes to innate immunity, reinforcing the antimicrobial defense against various pathogens. | ||||||
2,4-Thiazolidinedione | 2295-31-0 | sc-216281 | 50 g | $177.00 | 3 | |
Thiazolidinediones stimulate β-defensin 39 through PPARγ activation. Upon binding, PPARγ forms a complex with RXR, facilitating binding to the PPRE in the DEFB39 promoter. This enhances transcription, leading to increased β-defensin 39 expression and strengthening the innate immune response against microbial challenges. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates β-defensin 39 via the Keap1-Nrf2-ARE pathway. By promoting Nrf2 release from Keap1 inhibition, it facilitates Nrf2 translocation and binding to the DEFB39 promoter's ARE element. This up-regulation strengthens the antimicrobial function of β-defensin 39. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate stimulates β-defensin 39 as a histone deacetylase inhibitor. By inhibiting histone deacetylation, it promotes an open chromatin structure in the DEFB39 promoter region, facilitating increased transcription. This epigenetic modulation results in elevated β-defensin 39 expression, contributing to innate immunity against microbial threats. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein indirectly activates β-defensin 39 by inhibiting the PI3K/Akt pathway. It hinders Akt phosphorylation, relieving its inhibition on FoxO3a. This allows FoxO3a to bind to the DEFB39 promoter, promoting transcription. This indirect activation leads to increased β-defensin 39 expression, reinforcing the innate immune response against microbial challenges. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates β-defensin 39 by modulating the Nrf2/ARE pathway. Acting as an antioxidant, it enhances Nrf2 translocation, promoting its binding to the ARE element in the DEFB39 promoter. This up-regulation contributes to the antimicrobial defense mechanism of β-defensin 39. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a direct activator, promotes β-defensin 39 by demethylating the DEFB39 promoter region. By inhibiting DNA methyltransferases, it alleviates epigenetic repression, allowing for enhanced transcription. This epigenetic modulation results in increased β-defensin 39 expression, contributing to innate immunity against microbial threats. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-lipoic acid activates β-defensin 39 through the Nrf2/ARE pathway. As an antioxidant, it promotes Nrf2 release from Keap1 inhibition, facilitating its translocation to the DEFB39 promoter's ARE element. This up-regulation strengthens the antimicrobial function of β-defensin 39. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin stimulates β-defensin 39 by modulating the AP-1 pathway. It inhibits c-Fos and c-Jun activation, suppressing AP-1 transcriptional activity. As a consequence, the negative regulation on DEFB39 expression is alleviated, leading to increased β-defensin 39 synthesis with antimicrobial implications. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Diallyl disulfide activates β-defensin 39 by influencing the MAPK pathway. It enhances ERK1/2 phosphorylation, positively regulating AP-1, which binds to the DEFB39 promoter. This leads to increased transcription of β-defensin 39, fortifying the antimicrobial defense mechanism. | ||||||